Great question! Icotyde (icotrokinra) is a newly FDA-approved once-daily pill for moderate to severe plaque psoriasis in adults and teens 12+. It works by blocking the IL-23 receptor, which drives the inflammation behind psoriasis.
Here's what the clinical trial results showed:
- Around 70% of people reached "clear" or Show Full Answer
Great question! Icotyde (icotrokinra) is a newly FDA-approved once-daily pill for moderate to severe plaque psoriasis in adults and teens 12+. It works by blocking the IL-23 receptor, which drives the inflammation behind psoriasis.
Here's what the clinical trial results showed:
- Around 70% of people reached "clear" or "almost clear" skin by Week 16
- About 50% achieved complete skin clearance by Week 52 By comparison, newer biologics (like IL-23 or IL-17 inhibitors) have shown success rates of around 85–90%, with many people achieving complete clearance too.
So while Icotyde is a meaningful step forward — especially as a pill rather than an injection — biologics currently tend to show higher clearance rates overall.
That said, the big appeal of Icotyde is convenience. No needles, no injections, just a daily pill. For some people, that's a game-changer.
A chat with your dermatologist would help figure out which option fits your skin, lifestyle, and treatment history best.
August 3
Join
Your Privacy Choices
